Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2013

01.08.2013 | Original Article

The Efficacy and Safety of Neoadjuvant Chemotherapy in Treatment of Locally Advanced Carcinoma Cervix

verfasst von: Uma Singh, Neetu Ahirwar, Anju Kumari Rani, Nisha Singh, Pushplata Sankhwar, Sabuhi Qureshi

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

A prospective cohort study in a teaching hospital to assess the efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced carcinoma cervix.

Method

Neoadjuvant chemotherapy in the form of cisplatin 75 mg/m2 and paclitaxel 135 mg/m2 on day 1 and repeated at 14 days’ interval for up to a maximum of three courses.

Results

Neoadjuvant chemotherapy in cervical cancer was effective in the downstaging of the disease. Downstaging was observed in 19.23 % of patients after two cycles and in 50 % of patients after three cycle of NACT. Operability increases to 33.3 and 38.4 % after two and three cycles of NACT, respectively. Complete pathological response was observed in 37.5 % of patients after NACT. No significant adverse effect in the feasibility of surgery was observed.

Conclusion

The present study showed that neoadjuvant chemotherapy was an effective and well-tolerated mode of therapy with significantly less morbidity and mortality.
Literatur
1.
Zurück zum Zitat Poveda A, Martin AG. Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update. Ann Oncol. 2008;19:70–6.CrossRef Poveda A, Martin AG. Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update. Ann Oncol. 2008;19:70–6.CrossRef
2.
Zurück zum Zitat Rose PG. Combined-modality therapy of locally advanced cervical cancer. J Clin Oncol. 2003;21:211s–7s.PubMedCrossRef Rose PG. Combined-modality therapy of locally advanced cervical cancer. J Clin Oncol. 2003;21:211s–7s.PubMedCrossRef
3.
Zurück zum Zitat Green JA, Klirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.PubMedCrossRef Green JA, Klirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.PubMedCrossRef
4.
Zurück zum Zitat Gonzalez AD, Cetina L, Mariscal I, et al. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003;29:389–99.CrossRef Gonzalez AD, Cetina L, Mariscal I, et al. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003;29:389–99.CrossRef
5.
Zurück zum Zitat Gonzalez AD, Lopea-Graniell CM, Mota A, et al. Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma. J Clin Oncol. 2002;20:2908–10. Gonzalez AD, Lopea-Graniell CM, Mota A, et al. Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma. J Clin Oncol. 2002;20:2908–10.
6.
Zurück zum Zitat Sardi J, Giaroli A, Sananes C, et al.. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer. 2002;6:85–93.CrossRef Sardi J, Giaroli A, Sananes C, et al.. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer. 2002;6:85–93.CrossRef
7.
Zurück zum Zitat Singh KC, Agarwal A, Agarwal S, et al.. ‘Quick course’ neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer. Gynecol Obstet Invest. 2004;58:109–13.PubMedCrossRef Singh KC, Agarwal A, Agarwal S, et al.. ‘Quick course’ neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer. Gynecol Obstet Invest. 2004;58:109–13.PubMedCrossRef
8.
Zurück zum Zitat Taneja A, Rajaram S, Agarwal S, et al. “Quick cycle” neoadjuvant chemotherapy in squamous cell carcinoma of cervix. Indian J Pharmacol. 2005;37(5):320–4.CrossRef Taneja A, Rajaram S, Agarwal S, et al. “Quick cycle” neoadjuvant chemotherapy in squamous cell carcinoma of cervix. Indian J Pharmacol. 2005;37(5):320–4.CrossRef
9.
Zurück zum Zitat Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2008;20:660–5.CrossRef Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2008;20:660–5.CrossRef
10.
Zurück zum Zitat Toita T, Sakumoto K, Hiqashi M, et al. Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol. 1997;64:421–4.CrossRef Toita T, Sakumoto K, Hiqashi M, et al. Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol. 1997;64:421–4.CrossRef
11.
Zurück zum Zitat Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004;(2):CD001774 Review. PMID: 15106161. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004;(2):CD001774 Review. PMID: 15106161.
12.
Zurück zum Zitat Martin AG, Cortijo LG, Carballo N, et al. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma. Gynecol Oncol. 2008;110:S36–40.CrossRef Martin AG, Cortijo LG, Carballo N, et al. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma. Gynecol Oncol. 2008;110:S36–40.CrossRef
13.
Zurück zum Zitat Candelaria M, Vilchis JC, Cetina L, et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol. 2006;3:3.PubMedCrossRef Candelaria M, Vilchis JC, Cetina L, et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol. 2006;3:3.PubMedCrossRef
14.
Zurück zum Zitat Gonzalez AD, Graniell CL, Enciso AG, et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: result from two consecutive phase II studies. Ann Oncol. 2002;13:1212–9.CrossRef Gonzalez AD, Graniell CL, Enciso AG, et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: result from two consecutive phase II studies. Ann Oncol. 2002;13:1212–9.CrossRef
Metadaten
Titel
The Efficacy and Safety of Neoadjuvant Chemotherapy in Treatment of Locally Advanced Carcinoma Cervix
verfasst von
Uma Singh
Neetu Ahirwar
Anju Kumari Rani
Nisha Singh
Pushplata Sankhwar
Sabuhi Qureshi
Publikationsdatum
01.08.2013
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2013
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-012-0342-6

Weitere Artikel der Ausgabe 4/2013

The Journal of Obstetrics and Gynecology of India 4/2013 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.